The Impact of Vaginal Washing on Cervical Inflammation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorUniversity of Washington

About this trial

Vaginal washing is a common practice that many women perceive as hygienic. However, vaginal washing has been linked to adverse reproductive health outcomes including increased HIV acquisition risk. The mechanism linking vaginal washing to HIV risk remains unknown, but may be related to increased inflammation caused by intravaginal washing practices. The primary objective of this study is to test the hypothesis that a vaginal washing cessation intervention will reduce concentrations of soluble inflammatory mediators in cervicovaginal fluid and total immune cells in mucosal tissue, reduce cervical epithelial disruption, and increase concentrations of protective vaginal Lactobacillus spp. compared to control.

Eligibility criteria

Qualifiers

Reports vaginal washing beyond the introitus in the past week

Female, aged 18-50

Presence of a cervix

Informed consent obtained and form signed

Disqualifiers

<3 months postpartum or current breastfeeding

Current menstruation (can enroll after menses)

History of bleeding disorder

Visible cervical abnormality requiring evaluation

Trial design

Treatments tested in this trial

  • Vaginal washing cessation

Treatment groups

122 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Washington

Lead sponsor

National Institutes of Health (NIH)

Collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator